BOTTOM LINE: The NASDAQ Biotech Index has been in a trading range for 10 months. My short-term trading indicators generated buy signals on this index early last week. It proceeded to break through the 800 resistance level on Thursday, with a confirmation of the break on Friday. Partnerships with major pharmaceutical companies, FDA approvals and low interests rates should propel this sector higher in the intermediate-term.
No comments:
Post a Comment